Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal tissues. The α-emitting radionuclide bismuth-213 ((...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahenkorah, Stephen, Cassells, Irwin, Deroose, Christophe M., Cardinaels, Thomas, Burgoyne, Andrew R., Bormans, Guy, Ooms, Maarten, Cleeren, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143329/
https://www.ncbi.nlm.nih.gov/pubmed/33919391
http://dx.doi.org/10.3390/pharmaceutics13050599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143329/
https://www.ncbi.nlm.nih.gov/pubmed/33919391
http://dx.doi.org/10.3390/pharmaceutics13050599

Ejemplares similares